fashion -WSS

fashion

author：Wikipedia 2025-09-30 00:46:17 - browse：469

Adderall XR capsules are displayed on Feb. 24, 2023. Drug shortages are growing in the United States, and experts see no clear path to resolving them. — There has been a persistent shortage of the ADHD drug Adderall. Jenny Kane/AP

My first exposure to pharmaceutical shortages happened in 2017 as a new-to-practice nurse working on an inpatient oncology unit. A hurricane in Puerto Rico had left the U.S. short of sodium chloride minibags. Health care providers nationwide were tasked to modify standard medication preparation and administration practices, such as changing medications from IV to oral delivery, avoiding prepping IV lines with saline, or providing IV drugs by push rather than infusion. I was working in a heavily resourced academic institution. It felt absurd that I couldn’t even appropriately administer medications, but I figured this was an emergency.

Eventually, the shortage ended. But it was not an isolated incident.

The recent spotlight on shortages of essential medicines, such as cancer therapies and ADHD drugs, has brought attention to a longstanding public health crisis. Prescription drug shortages across drug classes have been on the radar of our governing bodies for decades. Nearly 10 years ago, up to 83% of oncologists surveyed could not prescribe a preferred chemotherapy agent due to shortages. Yet, the problem persists, with new shortages being identified at alarming rates. Recent reports indicate drug shortages grew by 30% in the past year. At the end of 2022, there were national shortages of 295 medications, including essentials like anesthetics, chemotherapies, and antibiotics.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Pharma showers House GOP doctor with campaign cash

focus

WSS

CVS Caremark has created a new ploy: the drug ‘rebate credit’

UnitedHealth increases loan offers after Change Healthcare outage

When waiting feels immoral: Empathy in the emergency department

Stop the failed accountable care organization experiment

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

leisure time

fashion

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Heart disease in astronauts blamed on cosmic radiation

Medicare details structure of new drug price negotiation program

Leading voice in opioid treatment defends methadone clinic system

Continuity nursing helped my family in our darkest PICU moments

CVS Caremark has created a new ploy: the drug ‘rebate credit’

BioMarin wins approval for gene therapy to treat hemophilia A

Virtual Event: March of the Biosimilars

Bright Health sells Medicare Advantage business to Molina

CDC recommends RSV monoclonal antibody for infants

hotspot

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

Methadone treatment changes are coming. Do they go far enough?

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

Pharma showers House GOP doctor with campaign cash

Baby aspirin cuts fat buildup in liver disease patients, in small study

Alnylam reports growth in sales of rare disease treatments

focus

focus

focus

hotspot